Literature DB >> 25852082

A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.

Guan-Sheng Liu1, Ana Morales2, Elizabeth Vafiadaki3, Chi Keung Lam1, Wen-Feng Cai4, Kobra Haghighi1, George Adly1, Ray E Hershberger5, Evangelia G Kranias6.   

Abstract

AIMS: Depressed sarcoplasmic reticulum (SR) Ca(2+) cycling, a universal characteristic of human and experimental heart failure, may be associated with genetic alterations in key Ca(2+)-handling proteins. In this study, we identified a novel PLN mutation (R25C) in dilated cardiomyopathy (DCM) and investigated its functional significance in cardiomyocyte Ca(2+)-handling and contractility. METHODS AND
RESULTS: Exome sequencing identified a C73T substitution in the coding region of PLN in a family with DCM. The four heterozygous family members had implantable cardiac defibrillators, and three developed prominent ventricular arrhythmias. Overexpression of R25C-PLN in adult rat cardiomyocytes significantly suppressed the Ca(2+) affinity of SR Ca(2+)-ATPase (SERCA2a), resulting in decreased SR Ca(2+) content, Ca(2+) transients, and impaired contractile function, compared with WT-PLN. These inhibitory effects were associated with enhanced interaction of R25C-PLN with SERCA2, which was prevented by PKA phosphorylation. Accordingly, isoproterenol stimulation relieved the depressive effects of R25C-PLN in cardiomyocytes. However, R25C-PLN also elicited increases in the frequency of Ca(2+) sparks and waves as well as stress-induced aftercontractions. This was accompanied by increased Ca(2+)/calmodulin-dependent protein kinase II activity and hyper-phosphorylation of RyR2 at serine 2814.
CONCLUSION: The findings demonstrate that human R25C-PLN is associated with super-inhibition of SERCA2a and Ca(2+) transport as well as increased SR Ca(2+) leak, promoting arrhythmogenesis under stress conditions. This is the first mechanistic evidence that increased PLN inhibition may impact both SR Ca(2+) uptake and Ca(2+) release activities and suggests that the human R25C-PLN may be a prognostic factor for increased ventricular arrhythmia risk in DCM carriers. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Calcium cycling; Dilated cardiomyopathy; Mutation

Mesh:

Substances:

Year:  2015        PMID: 25852082      PMCID: PMC4490203          DOI: 10.1093/cvr/cvv127

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  45 in total

1.  Spike frequency decoding and autonomous activation of Ca2+-calmodulin-dependent protein kinase II in dorsal root ganglion neurons.

Authors:  F Eshete; R D Fields
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

2.  Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure.

Authors:  K Haghighi; A G Schmidt; B D Hoit; A G Brittsan; A Yatani; J W Lester; J Zhai; Y Kimura; G W Dorn; D H MacLennan; E G Kranias
Journal:  J Biol Chem       Date:  2001-04-27       Impact factor: 5.157

3.  Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo.

Authors:  J Zhai; A G Schmidt; B D Hoit; Y Kimura; D H MacLennan; E G Kranias
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

4.  The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility.

Authors:  E Zvaritch; P H Backx; F Jirik; Y Kimura; S de Leon; A G Schmidt; B D Hoit; J W Lester; E G Kranias; D H MacLennan
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

5.  Outcome in phospholamban R14del carriers: results of a large multicentre cohort study.

Authors:  Ingrid A W van Rijsingen; Paul A van der Zwaag; Judith A Groeneweg; Eline A Nannenberg; Jan D H Jongbloed; Aeilko H Zwinderman; Yigal M Pinto; Ronald H Lekanne Dit Deprez; Jan G Post; Hanno L Tan; Rudolf A de Boer; Richard N W Hauer; Imke Christiaans; Maarten P van den Berg; J Peter van Tintelen; Arthur A M Wilde
Journal:  Circ Cardiovasc Genet       Date:  2014-06-08

6.  Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure.

Authors:  F del Monte; E Williams; D Lebeche; U Schmidt; A Rosenzweig; J K Gwathmey; E D Lewandowski; R J Hajjar
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

7.  Targeting phospholamban by gene transfer in human heart failure.

Authors:  Federica del Monte; Sian E Harding; G William Dec; Judith K Gwathmey; Roger J Hajjar
Journal:  Circulation       Date:  2002-02-26       Impact factor: 29.690

8.  Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality.

Authors:  Krisztina Zsebo; Alex Yaroshinsky; Jeffrey J Rudy; Kim Wagner; Barry Greenberg; Mariell Jessup; Roger J Hajjar
Journal:  Circ Res       Date:  2013-09-24       Impact factor: 17.367

9.  Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.

Authors:  Jeffrey R Erickson; Laetitia Pereira; Lianguo Wang; Guanghui Han; Amanda Ferguson; Khanha Dao; Ronald J Copeland; Florin Despa; Gerald W Hart; Crystal M Ripplinger; Donald M Bers
Journal:  Nature       Date:  2013-09-29       Impact factor: 49.962

10.  Nitric oxide-dependent activation of CaMKII increases diastolic sarcoplasmic reticulum calcium release in cardiac myocytes in response to adrenergic stimulation.

Authors:  Jerry Curran; Lifei Tang; Steve R Roof; Sathya Velmurugan; Ashley Millard; Stephen Shonts; Honglan Wang; Demetrio Santiago; Usama Ahmad; Matthew Perryman; Donald M Bers; Peter J Mohler; Mark T Ziolo; Thomas R Shannon
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more
  39 in total

1.  Phosphorylation of cardiac myosin-binding protein-C contributes to calcium homeostasis.

Authors:  Mohit Kumar; Kobra Haghighi; Evangelia G Kranias; Sakthivel Sadayappan
Journal:  J Biol Chem       Date:  2020-06-18       Impact factor: 5.157

2.  Phospholamban regulates nuclear Ca2+ stores and inositol 1,4,5-trisphosphate mediated nuclear Ca2+ cycling in cardiomyocytes.

Authors:  Mu Chen; Dongzhu Xu; Adonis Z Wu; Evangelia Kranias; Shien-Fong Lin; Peng-Sheng Chen; Zhenhui Chen
Journal:  J Mol Cell Cardiol       Date:  2018-09-24       Impact factor: 5.000

Review 3.  Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.

Authors:  Elizabeth M McNally; Luisa Mestroni
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

4.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

5.  Atrial fibrillation risk loci interact to modulate Ca2+-dependent atrial rhythm homeostasis.

Authors:  Brigitte Laforest; Wenli Dai; Leonid Tyan; Sonja Lazarevic; Kaitlyn M Shen; Margaret Gadek; Michael T Broman; Christopher R Weber; Ivan P Moskowitz
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

Review 6.  Calcium Signaling and Cardiac Arrhythmias.

Authors:  Andrew P Landstrom; Dobromir Dobrev; Xander H T Wehrens
Journal:  Circ Res       Date:  2017-06-09       Impact factor: 17.367

Review 7.  Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.

Authors:  Antoine Bondue; Eloisa Arbustini; Anna Bianco; Michele Ciccarelli; Dana Dawson; Matteo De Rosa; Nazha Hamdani; Denise Hilfiker-Kleiner; Benjamin Meder; Adelino F Leite-Moreira; Thomas Thum; Carlo G Tocchetti; Gilda Varricchi; Jolanda Van der Velden; Roddy Walsh; Stephane Heymans
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

8.  Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814.

Authors:  G Mazzocchi; L Sommese; J Palomeque; J I Felice; M N Di Carlo; D Fainstein; P Gonzalez; P Contreras; D Skapura; M D McCauley; E C Lascano; J A Negroni; E G Kranias; X H T Wehrens; C A Valverde; A Mattiazzi
Journal:  J Physiol       Date:  2016-02-02       Impact factor: 5.182

9.  Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Delaine K Ceholski; Irene C Turnbull; Chi-Wing Kong; Simon Koplev; Joshua Mayourian; Przemek A Gorski; Francesca Stillitano; Angelos A Skodras; Mathieu Nonnenmacher; Ninette Cohen; Johan L M Björkegren; Daniel R Stroik; Razvan L Cornea; David D Thomas; Ronald A Li; Kevin D Costa; Roger J Hajjar
Journal:  J Mol Cell Cardiol       Date:  2018-05-09       Impact factor: 5.000

Review 10.  Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals.

Authors:  Elham Kayvanpour; Farbod Sedaghat-Hamedani; Ali Amr; Alan Lai; Jan Haas; Daniel B Holzer; Karen S Frese; Andreas Keller; Katrin Jensen; Hugo A Katus; Benjamin Meder
Journal:  Clin Res Cardiol       Date:  2016-08-30       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.